| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2001;32:413.)
© 2001 American Heart Association, Inc.
Original Contributions |
From the Department of Neurology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
Correspondence to Gudrun Boysen, Professor of Neurology, Department of Neurology, Bispebjerg Hospital, Bispebjerg Bakke 23, DK-2400 Copenhagen NV, Denmark. E-mail gb01{at}bbh.hosp.dk
| Abstract |
|---|
|
|
|---|
MethodsThis
prospective study included 725 consecutive patients, 584 with cerebral
infarcts and 141 with intracerebral
hemorrhages, admitted to an acute stroke unit within 6 hours of
stroke onset. Time of stroke onset and time of admission were
recorded. Body temperature was measured on admission and every 2
hours during the first 24 hours. Patients were divided into 2 groups on
the basis of stroke severity on admission: Scandinavian Stroke Scale
Score (SSS)
25 was defined as major stroke, and SSS >25 was defined
as mild to moderate stroke.
ResultsOn admission, mean body temperature was normal. In the major stroke patients, body temperature started to rise 4 to 6 hours after stroke onset. At 10 to 12 hours after stroke onset, increased body temperature was found to be related to poor outcome. In mild to moderate stroke, there was no significant rise in temperature. Initial temperature >37.5°C was not related to stroke severity or stroke outcome.
ConclusionsIn major stroke, a significant rise in temperature occurred hours after stroke onset. Severe infarcts and intracerebral hemorrhages caused temperature to rise, whereas initially increased temperature had no influence on stroke severity. Elevated body temperature on admission within 6 hours of stroke onset had no prognostic influence on stroke outcome at 3 months.
Key Words: body temperature cerebral infarction hyperthermia intracerebral hemorrhage outcome
| Introduction |
|---|
|
|
|---|
The aims of the present study were to test the hypothesis that initial temperature is of significance for stroke outcome and to describe the time course of body temperature in acute stroke.
| Subjects and Methods |
|---|
|
|
|---|
Aspirin 150 mg/d plus dipyridamole retarded formulation 400 mg/d was standard antiplatelet treatment after cerebral infarction in the unit starting after the CT scan. Anticoagulant treatment was prescribed in atrial fibrillation and, in some cases of stroke in progression, after individual consideration. No patients were treated with thrombolysis. Fifty-nine patients were included in randomized, placebo-controlled trials with either low-molecular-weight heparin or neuroprotective substances. So far, none of these treatments have shown beneficial effect. Neurological deficits were assessed with the Scandinavian Stroke Scale (SSS)2 on admission and on days 2, 4, and 7.
Nurses assessed motor function and speech; reported vital values, including body temperature, every 2 hours for the first 24 hours and every 4 hours for the next 24 hours; and recorded the values on a special form. Vital values were registered within minutes of hospital arrival. Body temperature was measured as a tympanic temperature with First Temp Genius 3000A thermometers. The precision of this particular device has been validated in a number of studies, most of which found the thermometer accurate, reproducible, and highly correlated to pulmonary artery, esophageal, or rectal temperature.3 4 5 6 7 8 9 A Norwegian study reported that it was imprecise and generally gave too high readings,10 and one study concluded that the measured temperatures were generally too low compared with rectal temperatures.11 Patients with body temperature >37°C were treated with paracetamol 1 g; this treatment did not exclude any patients from this study.
The degree of handicap was assessed by the modified Rankin Scale (mRS)12 at 3 months; death was rated as 6. mRS at 3 months was not performed systematically until July 1998, and in total, mRS was missing in 111 patients. However, we obtained information on all patients as to whether they were alive or dead at 3 months.
The patients were divided into 2 groups on the basis of
stroke severity on admission. SSS
25 was selected as a cutoff point
because patients with lower scores were all nonambulant with other
severe deficits. We called this group the major stroke group and those
with SSS >25 the mild to moderate stroke group. Deteriorating stroke
was defined as a deterioration of the neurological deficit of
2
points lasting >4 hours.
Statistical analysis was done with SPSS 9.0 for
Windows. Nonparametric methods (Spearmans
,
Kolmogorov-Smirnovs z test,
multinomial logistic regression) were performed on ordinal scale data.
Parametric methods (t
test) were used for continuous data.
The Scientific-Ethical Committee found that the study was not of such a biomedical kind that it was within its coverage. The committee had no objections to the study or its conduct.
| Results |
|---|
|
|
|---|
|
|
In total, 316 patients (44%) were given
1 dose of
paracetamol within 18 hours of stroke onset on this indication. One
hundred fifty-nine patients (22%) had
1 temperature measurement
exceeding 37°C without receiving paracetamol. In the group of
patients with a peak temperature exceeding 37°C, we compared patients
who actually received paracetamol with patients not receiving
paracetamol and found that the peak temperature was higher in patients
receiving paracetamol (37.6°C versus 37.4°C in patients not
receiving paracetamol;
P<0.001,
t test). We also found that the
mean temperature over the first 18 hours in patients receiving
paracetamol was higher (36.9°C versus 36.7°C;
P=0.002,
t test). We found no
differences as to age, stroke severity, or outcome.
In 88 patients, body temperature exceeded 38°C at some
time point during the first 2 days. In 16% of these patients, clinical
signs of infection required treatment with antibiotics within the first
2 days of stroke onset. Deteriorating stroke occurred in 19% of
patients with infarctions and 43% of patients with
intracerebral hemorrhages. Patients who
deteriorated had more severe strokes, higher mortality, and
significantly (P=0.042,
t test) lower body temperature
on admission
(Table 3
). Mean temperature on admission in patients who
died within 7 days (36.5°C) or 3 months (36.5°C) tended to be lower
than in survivors (36.6°C;
P=0.086,
t test).
|
In 93 patients, body temperature on admission was <36°C.
These patients had more severe strokes than patients with higher
temperature (median SSS on admission, 24 versus 37;
P<0.001, Kolmogorov-Smirnovs
z test). The 7-day fatality
rate was higher in patients with lower body temperature on admission
(21% versus 10%; P=0.002,
2). No difference was found in survivors
at 3 months.
To demonstrate a possible relationship between body
temperature in the first hours after stroke onset and outcome at 3
months, we performed multiple Spearman correlation tests of mRS,
including death versus body temperature at different time points
(Table 4
). Correlation was found between lower temperature
and less favorable outcome on admission within 6 hours of stroke onset.
At 8 hours after stroke onset and later, a significant correlation
between higher temperature and less favorable outcome was demonstrated.
In patients admitted within 2 hours of stroke onset, no correlation was
found between body temperature on admission and outcome.
|
Cerebral Infarctions
A rise in body temperature was observed in some
patients. This rise in body temperature was related to initial stroke
severity and started 4 to 6 hours after stroke onset in the major
stroke patients
(Figure 1
). No change in temperature was observed in the
patients with mild to moderate strokes
(Figure 2
).
|
|
To evaluate factors with possible influence on stroke outcome, we performed a multinomial logistic regression test of SSS on admission, age, sex, prestroke mRS, history of atrial fibrillation, p-glucose, and body temperature on admission versus mRS at 3 months as a measure of outcome. The following factors reached significance in this model: Older age (P<0.001), low SSS on admission (P<0.001), and high prestroke mRS (P=0.001) negatively affected outcome in this model. The model significance was P<0.001.The explanatory value of the model was moderate (pseudo-R2=0.468, Cox and Snell).
In 65% of cases, the first dose of antiplatelet therapy was given on the day of admission, usually 8 to 12 hours after stroke onset.
Intracerebral
Hemorrhages
A substantial rise in body temperature was also
observed in these patients within the first 12 hours. In the major
stroke group
(Figure 3
), mean body temperature started to rise 4 to 6
hours after stroke onset and rose 1°C. In the moderate hemorrhagic
stroke patients, an uncertain tendency toward an increase was observed
(Figure 4
).
|
|
To evaluate factors with possible influence on stroke outcome, we performed a multinomial logistic regression test of SSS on admission, age, sex, prestroke mRS, history of atrial fibrillation, p-glucose, C-reactive protein, and body temperature on admission versus mRS at 3 months as a measure of outcome. The following factors contributed in this model: Low SSS on admission (P<0.001), older age (P=0.035), and high prestroke mRS (P<0.001) negatively affected outcome in this model. The model significance was P<0.001. The explanatory value of the model was moderate (pseudo-R2=0.673, Cox and Snell).
| Discussion |
|---|
|
|
|---|
Could the difference between our findings and those of others be due to the thermometer, the electronic tympanic device? This is not likely because a similar device was used by some investigators15 and axillary temperature was used by others.14 Even if the tympanic thermometer might have a lower reproducibility than the rectal mercury thermometer, this is not likely to have invalidated our data, which included >4000 temperature measurements. Treatment with paracetamol in patients with temperatures >37°C probably blunted the rise in temperature but had no influence on admission temperature. We cannot exclude that treatment with paracetamol in 12 of the 35 patients with initially increased temperature may have had a beneficial effect on outcome. The effect of paracetamol has not been formally studied in stroke patients except in a small study17 in which intracerebral temperature was found to be unaffected by paracetamol.
The present study shows that when temperature is measured soon enough, only low initial temperature is related to stroke severity. We assume that low temperature on admission could be due to exposure in the period from stroke onset to hospital admission. The severe stroke patients may loose body temperature faster during transportation as a result of a lack of muscle activity.
Stroke severity determines the later rise in temperature. This does not exclude the possibility that a sustained rise in temperature during the first 24 to 36 hours may have a detrimental effect and further aggravate the neurological deficit or that induced hypothermia may be beneficial. This, however, has to be shown in randomized, controlled studies.
| Acknowledgments |
|---|
Received August 11, 2000; revision received November 3, 2000; accepted November 8, 2000.
| References |
|---|
|
|
|---|
2. Lindenstrøm E, Boysen G, Christiansen LW, á Rogvi Hansen B, Nielsen BW. Reliability of Scandinavian Stroke Scale. Cerebrovasc Dis. 1991;1:103107.
3. Edge G, Morgan M. The genius infrared tympanic thermometer: an evaluation for clinical use. Anaesthesia. 1993;48:604607.[Medline] [Order article via Infotrieve]
4. Klein DG, Mitchell C, Petrinec A, Monroe MK, Oblak M, Ross B, Youngblut JM. A comparison of pulmonary artery, rectal and tympanic membrane temperature measurement in the ICU. Heart Lung. 1993;22:435441.[Medline] [Order article via Infotrieve]
5. Matsukukawa T, Ozaki M, Hanagata K, Iwashita H, Miyaji T, Kumazawa T. A comparison of four infrared tympanic thermometers with tympanic temperatures measured by thermocouples. Can J Anaesth. 1996;43:12241228.[Medline] [Order article via Infotrieve]
6. Shinozaki T, Deane R, Perkins FM. Infrared tympanic thermometer: evaluation of a new clinical thermometer. Crit Care Med. 1988;16:149150.
7. Smith DL, Fehling PC. Reliability of infrared tympanic thermometry (ITT). Aviat Space Environ Med. 1996;67:272274.[Medline] [Order article via Infotrieve]
8. Steward JV, Webster D. Re-evaluation of the tympanic thermometer in the emergency department. Ann Emerg Med. 1992;21:158161.[Medline] [Order article via Infotrieve]
9. Summers S. Axillary, tympanic and esophageal temperature measurement: descriptive comparisons in postanesthesia patients. J Post Anaesth Nurs. 1991;6:420425. Abstract [Medline].[Medline] [Order article via Infotrieve]
10. Fremstad ML, Holden GM, Anke AG, Stanghelle JK. Infrared tympanic thermometry: worse than reported? Tidsskr Nor Laegeforen. 1993;113:27082710.[Medline] [Order article via Infotrieve]
11. Hooker EA, Houston H. Screening for fever in an adult emergency department: oral vs tympanic thermometry. South Med J. 1996;89:230234.[Medline] [Order article via Infotrieve]
12.
van Swieten JC,
Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver
agreement for the assessment of handicap in stroke patients.
Stroke. 1988;19:604607.
13.
Schwarz S,
Häfner K, Aschoff A, Schwab S. Incidence and prognostic significance
of fever following intracerebral hemorrhage.
Neurology. 2000;54:354361.
14.
Castillo J,
Davalos A, Marrugat J, Noya M. Timing for fever-related brain damage in
acute ischemic stroke.
Stroke. 1998;29:24552460.
15. Reith J, Jørgensen HS, Pedersen PM, Nakayama H, Raaschou HO, Jeppesen LL, Olsen TS. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet. 1996;347:422425.[Medline] [Order article via Infotrieve]
16.
Wang Y, Lim L
L-Y, Levi C, Heller RF, Fisher J. Influence of admission body
temperature on stroke mortality.
Stroke. 2000;31:404409.
17.
Schwab S,
Spranger M, Aschoff A, Steiner T, Hacke W. Brain temperature monitoring
and modulation in patients with severe MCA infarctions.
Neurology. 1997;48:762767.
This article has been cited by other articles:
![]() |
N. L. Reaven, J. E. Lovett, and S. E. Funk Brain Injury and Fever: Hospital Length of Stay and Cost Outcomes J Intensive Care Med, March 1, 2009; 24(2): 131 - 139. [Abstract] [PDF] |
||||
![]() |
D. M. Greer, S. E. Funk, N. L. Reaven, M. Ouzounelli, and G. C. Uman Impact of Fever on Outcome in Patients With Stroke and Neurologic Injury: A Comprehensive Meta-Analysis Stroke, November 1, 2008; 39(11): 3029 - 3035. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chamorro, X. Urra, and A. M. Planas Infection After Acute Ischemic Stroke: A Manifestation of Brain-Induced Immunodepression Stroke, March 1, 2007; 38(3): 1097 - 1103. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sanossian, J. L. Saver, V. Rajajee, S. L. Selco, D. Kim, T. Razinia, and B. Ovbiagele Premorbid antiplatelet use and ischemic stroke outcomes Neurology, February 14, 2006; 66(3): 319 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
Part 9: Adult Stroke Circulation, December 13, 2005; 112(24_suppl): IV-111 - IV-120. [Full Text] [PDF] |
||||
![]() |
D. A. Godoy, A. Boccio, R. Leira, and J. Castillo Early neurologic deterioration in intracerebral hemorrhage: Predictors and associated factors Neurology, March 8, 2005; 64(5): 931 - 932. [Full Text] [PDF] |
||||
![]() |
H Christensen, G Boysen, A F Christensen, and H H Johannesen Insular lesions, ECG abnormalities, and outcome in acute stroke J. Neurol. Neurosurg. Psychiatry, February 1, 2005; 76(2): 269 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Audebert, M. M. Rott, T. Eck, and R. L. Haberl Systemic Inflammatory Response Depends on Initial Stroke Severity but Is Attenuated by Successful Thrombolysis Stroke, September 1, 2004; 35(9): 2128 - 2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Dziedzic, A. Slowik, and A. Szczudlik Serum Albumin Level as a Predictor of Ischemic Stroke Outcome Stroke, June 1, 2004; 35(6): e156 - e158. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takagi, T. Fujimaki, L. P. Kammersgaard, and T. S. Olsen Does Admission Body Temperature Predict Mortality After Acute Stroke? Stroke, January 1, 2003; 34(1): 5 - 6. [Full Text] [PDF] |
||||
![]() |
K. Takagi, G. Boysen, and H. Christensen Body Temperature in Acute Stroke * Response Stroke, September 1, 2002; 33(9): 2154 - 2155. [Full Text] [PDF] |
||||
![]() |
H.-C. Koennecke and S. Leistner Prophylactic antipyretic treatment with acetaminophen in acute ischemic stroke:: A pilot study Neurology, December 26, 2001; 57(12): 2301 - 2303. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Boysen and H. Christensen Early Stroke: A Dynamic Process Stroke, October 1, 2001; 32(10): 2423 - 2425. [Full Text] [PDF] |
||||
![]() |
D. W.J. Dippel, E. J. van Breda, H. M.A. van Gemert, H. B. van der Worp, R. J. Meijer, L. J. Kappelle, and P. J. Koudstaal Effect of Paracetamol (Acetaminophen) on Body Temperature in Acute Ischemic Stroke : A Double-Blind, Randomized Phase II Clinical Trial Stroke, July 1, 2001; 32(7): 1607 - 1612. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.C. Sharma, G. Boysen, and H. Christensen Re: Stroke Severity Determines Body Temperature in Acute Stroke Response Stroke, July 1, 2001; 32(7): 1697 - 1697. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |